Ophthalmologic Involvement in Adults with Histiocytic Disorders Clinical Presentation and Treatment Outcomes

被引:5
|
作者
Banks, Samantha A. [1 ]
Bhatti, M. Tariq [1 ,2 ]
Go, Ronald S. [3 ]
Abeykoon, Jithma P. [3 ]
Acosta-Medina, Aldo A. [4 ]
Hazim, Antonious Z. [4 ]
Goyal, Gaurav [5 ]
Young, Jason R. [6 ]
Koster, Matthew J. [7 ]
Vassallo, Robert [8 ]
Ryu, Jay H. [8 ]
Davidge-Pitts, Caroline J. [9 ]
Ravindran, Aishwarya [10 ]
Valinotti, Julio C. Sartori [11 ]
Bennani, N. Nora [3 ]
Shah, Mithun, V [3 ]
Rech, Karen L. [10 ]
Garrity, James A. [2 ]
Tobin, W. Oliver [1 ]
机构
[1] Mayo Clin, Div Neurol, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Ophthalmol, Coll Med, Rochester, MN 55905 USA
[3] Mayo Clin, Div Hematol, Coll Med, Rochester, MN 55905 USA
[4] Mayo Clin, Div Internal Med, Coll Med, Rochester, MN 55905 USA
[5] Univ Alabama Birmingham, Div Hematol Oncol, Birmingham, AL 35294 USA
[6] Mayo Clin, Div Radiol, Coll Med, Rochester, MN 55905 USA
[7] Mayo Clin, Div Rheumatol, Coll Med, Rochester, MN 55905 USA
[8] Mayo Clin, Div Pulm & Crit Care Med, Coll Med, Rochester, MN 55905 USA
[9] Mayo Clin, Coll Med, Div Endocrinol Diabet & Nutr, Rochester, MN 55905 USA
[10] Mayo Clin, Div Hernatopathol, Coll Med, Rochester, MN 55905 USA
[11] Mayo Clin, Div Dermatol, Coll Med, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Cavernous sinus; Histiocytosis; Optic nerve; Visual acuity; LANGERHANS-CELL HISTIOCYTOSIS; ERDHEIM-CHESTER-DISEASE; ROSAI-DORFMAN DISEASE; MANIFESTATIONS; SPECTRUM;
D O I
10.1016/j.ophtha.2022.07.031
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the clinical presentation, treatment, and outcomes in adult patients with histiocytic disorders with ocular, orbital, optic nerve, or cavernous sinus involvement. Design: Observational, retrospective chart review. Participants: Adult patients (age > 18 years) at Mayo Clinic from January 1, 1996, to July 1, 2021, with histiocytic disorders. Inclusion criteria were (1) histiocytic disorder by biopsy and appropriate clinical phenotype; (2) available medical records; and (3) ocular, orbital, optic nerve, or cavernous sinus involvement. Methods: Retrospective chart review. Main Outcome Measures: Response to therapy, measured in clinical and radiographic impact. Results: Thirty-two patients were identified: 7 with Langerhans cell histiocytosis (LCH); 15 with ErdheimChester disease (ECD); 1 with mixed LCH/ECD phenotype; 8 with Rosai-Dorfman disease (RDD); and 1 with mixed RDD/ECD phenotype. Ophthalmologic involvement was part of the initial presentation in 69% of patients (22/32). Eyelid edema (13/32, 41%) and proptosis (12/32, 38%) were the most frequent presentations. Isolated orbital or cavernous sinus involvement was present in 3 of 7 patients with LCH and 1 of 8 patients with RDD. Optic nerve sheath involvement was present in 2 of 7 LCH patients, 14 of 15 ECD patients, and 1 RDD/ECD patient. Diffuse (> 75%) orbital involvement was seen in 12 of 15 ECD patients and 1 of 7 LCH patients. Ocular involvement was seen in 1 of 15 ECD patients, 6 of 8 RDD patients, and 1 of 1 mixed RDD/ECD patient. The cavernous sinuses were involved in 1 of 7 LCH patients, 5 of 15 ECD patients, and both mixed phenotype patients. Visual acuity was affected in 14 patients (14/24, 58%) with a median logarithm of the minimum angle of resolution visual acuity of 0.1 (range, -0.12 to 3). BRAF V600E mutations were found in 75% (3/4) of LCH patients and 91% (10/11) of ECD patients. Patients received a variety of treatment, and response was variable across disease types. Conclusions: Orbital involvement was more commonly seen in LCH and ECD, whereas ocular involvement was more common in RDD. Visual acuity may be impacted from ocular involvement or compression of the optic nerve with diffuse orbital involvement. Ophthalmology 2023;130:77-86 (c) 2022 by the American Academy of Ophthalmology
引用
收藏
页码:77 / 86
页数:10
相关论文
共 50 条
  • [31] Clinical Presentation and Treatment Outcomes of Recurrent Corneal Erosion
    Bae, Kyoung Hwa
    Ahn, Min
    Cho, Nam Chun
    You, In Cheon
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (04): : 555 - 561
  • [32] Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes
    Chandra, Kiran
    Raval, Vishal
    Reddy, Vijay Anand P.
    Kaliki, Swathi
    JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (05) : 367 - 373
  • [33] UTERINE SARCOMA: CLINICAL PRESENTATION, TREATMENT AND SURVIVAL OUTCOMES
    Potikul, C.
    Tangjitgamol, S.
    Khunnarong, J.
    Srijaipracharoen, S.
    Thavaramara, T.
    Pataradool, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1148 - 1148
  • [34] Riedel's thyroiditis: clinical presentation, treatment and outcomes
    Falhammar, Henrik
    Juhlin, Carl Christofer
    Barner, Caroline
    Catrina, Sergiu-Bogdan
    Karefylakis, Christos
    Calissendorff, Jan
    ENDOCRINE, 2018, 60 (01) : 185 - 192
  • [35] Riedel’s thyroiditis: clinical presentation, treatment and outcomes
    Henrik Falhammar
    Carl Christofer Juhlin
    Caroline Barner
    Sergiu-Bogdan Catrina
    Christos Karefylakis
    Jan Calissendorff
    Endocrine, 2018, 60 : 185 - 192
  • [36] Tuberculosis in the very elderly - clinical presentation and treatment outcomes
    Afonso, Miguel F. B.
    Ferro, Filipa
    Carvalho, Joana
    Cysneiros, Ana
    Castro, Ana Tavares E.
    Mourato, Teresa
    Gomes, Alexandre C.
    Gomes, Conceicao
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [37] Cutaneous involvement as a unique presentation of a histiocytic sarcoma: Case report and review of the literature
    Martin Lopez, J.
    Suarez Massa, D.
    Garcia Fresnadillo, D.
    Bellas Menendez, C.
    Gonzalez Lois, C.
    VIRCHOWS ARCHIV, 2015, 467 : S199 - S199
  • [38] A unique clinical presentation in a patient with primary histiocytic sarcoma of the brain
    Haldar, Sounick
    Baskovich, Brett
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 : S7 - S7
  • [39] BRAF Fusions in Histiocytic Disorders: Frequency and Clinical Characteristics
    Zanwar, Saurabh
    Abeykoon, Jithma P.
    Acosta-Medina, Aldo A.
    Ravindran, Aishwarya
    Rech, Karen
    Schwartz, Jonathan
    Bennani, Nora
    Shah, Mithun V.
    Morlote, Diana
    Goyal, Gaurav
    Go, Ronald
    BLOOD, 2021, 138
  • [40] Clinical and therapeutic implications of BRAF fusions in histiocytic disorders
    Saurabh Zanwar
    Jithma P. Abeykoon
    Surendra Dasari
    Aishwarya Ravindran
    Jason R. Young
    Aldo A. Acosta-Medina
    Karen L. Rech
    Jonathan Schwartz
    Aaron Mangold
    Allison Rosenthal
    N. Nora Bennani
    Mithun V. Shah
    Diana Morlote
    Gaurav Goyal
    Ronald S. Go
    Blood Cancer Journal, 12